Drug slows Alzheimer's but can it make a real difference? - Tofino-Ucluelet Westerly News
Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study
Stay updated with breaking news from Ron Petersen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study
An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening, researchers reported Tuesday -- but it remains unclear how much difference that might make in people’s lives. Japanese drugmaker Eisai and its U.S. partner Biogen had announced earlier this fall that the drug lecanemab appeared to work, a badly needed bright spot after repeated…
An experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening, researchers reported Tuesday – but it remains unclear how much difference that might make in people's lives.
An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening, researchers reported Tuesday—but it remains unclear whether that will have an impact on people’s lives.
New data shows an experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening